Well Referenced

Tag: Antithyroid Drugs

Management of Graves Thyroidal and Extrathyroidal Disease: An Update

This 2020 comprehensive review provides an updated framework for managing Graves’ disease, addressing both thyroidal hyperfunction and extrathyroidal manifestations such as thyroid eye disease (TED). Methimazole (MMI) is the first-line antithyroid medication, with a treatment duration of 12–18 months. Persistently elevated TSH receptor antibodies or recurrence of hyperthyroidism post-treatment warrants

Read More »
June 26, 2025 No Comments

Lugol’s Solution and Other Iodide Preparations: Perspectives and Research Directions in Graves’ Disease

This 2017 review examines the clinical utility and mechanistic insights of Lugol’s solution and other iodide preparations in the management of Graves’ disease. Historically used preoperatively to reduce thyroid hormone levels and gland vascularity, Lugol’s solution acts by inhibiting thyroid hormone synthesis and release. The review discusses the transient nature

Read More »
June 26, 2025 No Comments